Is the effectiveness of Carragelose clinically proven?

Yes. Multiple clinical trials involving nearly 600 adult and pediatric patients have demonstrated the safety and effectiveness of Carragelose nasal sprays in the treatment of the common cold.

In addition, in vitro studies have shown a non-specific virus-trapping effect against a broad range of respiratory viruses, including SARS-CoV-2. While Carragelose products cannot fully prevent viral infections, they may significantly reduce viral load and transmission risk.
Scientific publications are available upon request.